Clinical Trials/Research Study Participation Opportunities
Children and Adolescents -
Omega 3 Fatty Acids in the Treatment of Children
with Autism Spectrum Disorders - The Division of
Child and Adolescent Psychiatry, Department of Psychiatry,
University of Medicine and Dentistry of New Jersey (UMDNJ)
- Robert Wood Johnson Medical School (RWJMS), is currently
recruiting child volunteers aged 5 - 17 for a 12-week clinical
study examining the impact of Omega 3 Fatty Acids on irritability
associated with autism. To be eligible, participants must
have a diagnosis of autism. Participants diagnosed with
Mood Disorder NOS may also be eligible. Interview and questionnaire
completion will comprise 2-3 visits, each ranging from 1-3
hours. Those who qualify will be closely monitored by the
study doctor. Dietary supplements will be provided at no
cost. Sherie Novotny, MD, is the Principal Investigator.
For more information, please call Annie Kutlik, Clinical
Research Coordinator, at 732-235-5690.
Oxcarbazepine versus Placebo in Childhood Autism
- The Division of Child and Adolescent Psychiatry, Department
of Psychiatry, University of Medicine and Dentistry of New
Jersey (UMDNJ) - Robert Wood Johnson Medical School (RWJMS),
is currently recruiting child volunteers aged 5 - 17 for
a 12-week clinical drug study examining the impact of Oxcarbazepine
on mood instability and irritability associated with autism.
To be eligible, participants must have a diagnosis of autism
and must be willing to undergo an interview. The interview
and questionnaires may take up to four hours to complete.
The interview may be completed at a second visit if necessary.
Those who qualify will be closely monitored by the study
doctor. Medication will be provided at no cost. Sherie Novotny,
MD, is the Principal Investigator. For more information,
please call Annie Kutlik, Clinical Research Coordinator,
at 732-235-5690.
Aripiprazole versus Placebo in the Reduction of
Aggressive and Aberrant Behavior in Autistic Children -
The Division of Child and Adolescent Psychiatry, Department
of Psychiatry, University of Medicine and Dentistry of New
Jersey (UMDNJ) - Robert Wood Johnson Medical School (RWJMS),
is currently recruiting child volunteers aged 5 - 17 for
an 8-week clinical drug study examining the impact of Aripiprazole
on aggressive and aberrant behavior associated with autism.
To be eligible, participants must have a diagnosis of autism
and must be willing to undergo an interview. The interview
and questionnaires may take up to four hours to complete.
The interview may be completed at a second visit if necessary.
Those who qualify will be closely monitored by the study
doctor. Medication will be provided at no cost. Sherie Novotny,
MD, is the Principal Investigator. For more information,
please call Annie Kutlik, Clinical Research Coordinator,
at 732-235-5690.
An Open-Label, Prospective, Cohort Study of Antidepressants
in Children and Adolescents with Anxiety Disorders, Depressive
Disorders, Eating Disorders, or Obsessive-Compulsive Disorder
- The Division of Child and Adolescent Psychiatry,
Department of Psychiatry, University of Medicine and Dentistry
of New Jersey (UMDNJ) - Robert Wood Johnson Medical School
(RWJMS), is currently recruiting child volunteers aged 7
- 17, with anxiety disorders, depressive disorders, eating
disorders, or obsessive-compulsive disorder, to participate
in a study of the safety, tolerability, and effectiveness
of SSRI and SNRI antidepressants for children and adolescents
with anxiety disorders, depressive disorders, eating disorders,
or obsessive-compulsive disorder. This information will
help clinicians better understand the balance of risk and
benefit associated with these classes of medication. The
study will have two phases, an acute treatment phase following
initiation of treatment with any SSRI or SNRI of the clinician’s
choosing and a long-term follow up. The acute treatment
phase will last twelve (12) weeks and the long-term follow
up will occur six (6) and nine (9) months after initiation
of treatment. Children in this study must be under the care
of a child and adolescent psychiatrist and must be receiving
current, stable drug treatment for their behavioral or emotional
problem. Theodore A. Petti, MD, is the Principal Investigator.
For more information, please call Annie Kutlik, Clinical
Research Coordinator, at 732-235-5690.
Adults -
Do you have widespread pain or fibromyalgia? Researchers
at the Department of Psychiatry, Robert Wood Johnson Medical
School, are conducting a research study using Lunesta, an
FDA-approved drug for insomnia, to treat the symptoms of
fibromyalgia. You may qualify if you are between the ages
of 18 to 64, you have fibromyalgia, and you are having difficulty
sleeping. Participants will receive $20 per visit. For more
information, please call Lesley Allen, Ph.D., Principal
Investigator, Department of Psychiatry, Robert Wood Johnson
Medical School, Piscataway, NJ, at 732-235-4412 or 732-235-3378.
Are you bothered by multiple, persistent physical symptoms
(such as pain, fatigue, gastrointestinal difficulties or
menstrual difficulties)? Do you have fibromyalgia, irritable
bowel syndrome, chronic fatigue syndrome, TMJ, or chemical
sensitivities? You may be eligible for a free treatment
study. Dr. Lesley Allen is studying a new psychosocial treatment
designed to help reduce physical discomfort. Participants
must be 18-65 years of age and have multiple unexplained
physical symptoms. For more information, call Lesley Allen,
PhD, Department of Psychiatry, Robert Wood Johnson Medical
School, Piscataway, NJ, at 732-235-4412. Dr. Paul Lehrer,
of the Department of Psychiatry, Robert Wood Johnson Medical
School, Piscataway, NJ, is currently recruiting individuals
aged 18 - 70 who have multiple, unexplained physical symptoms
to participate in a study of the efficacy of a new biofeedback
treatment. Participants who, after screening, are determined
to be eligible for the study will be randomly assigned to
either a “treatment” group or a “waiting
list control” group. The treatment will comprise 10
weekly training sessions (approximately 1 hour each) in
muscle relaxation, a structured method of self-hypnosis
(autogenic training), and biofeedback (using physiological
monitoring equipment as a method to train people to control
their heart rate variability, breathing, and muscle tension).
Participants will be paid $25 each for the three evaluation
sessions. If interested, please call Maria Karavidas, PsyD,
at 732-235-4628 or e-mail karavima@umdnj.edu.
Have asthma? Often feel stressed or anxious? Do you have
one or more of these symptoms? Racing heart, sweating, chest
pain, choking, lightheadedness, dizziness, nausea, tingling,
chills, shaking, feelings of unreality, a need to escape.
All these can be symptoms of panic. Researchers at the Department
of Psychiatry, Robert Wood Johnson Medical School, Piscataway,
NJ, are testing a non-drug treatment for people who have
both asthma and panic. Treatment is free. Volunteers are
paid $25 for each of four testing sessions. For more information
please call Paul Lehrer, PhD, at 732-235-4413 or e-mail
lehrer@umdnj.edu.
Do you feel sad, irritable, tired, and uninterested? Do you have concentration,
appetite, and sleep problems? You may be suffering from
depression. Dr. Paul Lehrer, of the Department of Psychiatry,
Robert Wood Johnson Medical School, Piscataway, NJ, is conducting
a research study using a new, non-drug technique to treat
depression. Treatment does not involve medication. Participants
must be between the ages of 18 and 75 and medically stable.
This investigational treatment is provided at no cost. For
more information, please call Maria Karavidas, PsyD, at
732-235-4628 or karavima@umdnj.edu.
|
